Antibody response to SARS-CoV-2 in people living with HIV

doi:10.1016/j.jmii.2020.09.005

. 2021 Feb;54(1):144-146.

doi: 10.1016/j.jmii.2020.09.005. Epub 2020 Oct 2.

Antibody response to SARS-CoV-2 in people living with HIV

Shinya Yamamoto¹, Makoto Saito¹, Etsuko Nagai¹, Keiko Toriuchi¹, Hiroyuki Nagai¹, Hiroshi Yotsuyanagi¹, Yu Nakagama², Yasutoshi Kido², Eisuke Adachi³

Affiliations

¹ Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
² Department of Parasitology, Graduate Scholl of Medicine, Osaka City University, Osaka, Japan.
³ Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Electronic address: eadachi-ims@umin.ac.jp.

PMID: 33046418
PMCID: PMC7531336
DOI: 10.1016/j.jmii.2020.09.005

Antibody response to SARS-CoV-2 in people living with HIV

Shinya Yamamoto et al. J Microbiol Immunol Infect. 2021 Feb.

. 2021 Feb;54(1):144-146.

doi: 10.1016/j.jmii.2020.09.005. Epub 2020 Oct 2.

Authors

Shinya Yamamoto¹, Makoto Saito¹, Etsuko Nagai¹, Keiko Toriuchi¹, Hiroyuki Nagai¹, Hiroshi Yotsuyanagi¹, Yu Nakagama², Yasutoshi Kido², Eisuke Adachi³

Affiliations

¹ Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
² Department of Parasitology, Graduate Scholl of Medicine, Osaka City University, Osaka, Japan.
³ Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Electronic address: eadachi-ims@umin.ac.jp.

PMID: 33046418
PMCID: PMC7531336
DOI: 10.1016/j.jmii.2020.09.005

No abstract available

Keywords: COVID-19; HIV; PLWH; Seroconversion; Serology.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest None to declare.

Cited by

Brief communications: changes in inflammatory biomarkers and lipid profiles after switching to long-acting cabotegravir plus rilpivirine.
Adachi E, Saito M, Otani A, Koga M, Yotsuyanagi H. Adachi E, et al. AIDS Res Ther. 2024 Jan 3;21(1):1. doi: 10.1186/s12981-023-00590-4. AIDS Res Ther. 2024. PMID: 38173008 Free PMC article.
A Longitudinal Analysis of SARS-CoV-2 Antibody Responses Among People With HIV.
Alcaide ML, Nogueira NF, Salazar AS, Montgomerie EK, Rodriguez VJ, Raccamarich PD, Barreto IT, McGaugh A, Sharkey ME, Mantero AM, Rodriguez AE, Beauchamps L, Jones DL. Alcaide ML, et al. Front Med (Lausanne). 2022 Mar 7;9:768138. doi: 10.3389/fmed.2022.768138. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35330585 Free PMC article.
COVID-19 in People Living with HIV: A Systematic Review and Meta-Analysis.
Lee KW, Yap SF, Ngeow YF, Lye MS. Lee KW, et al. Int J Environ Res Public Health. 2021 Mar 30;18(7):3554. doi: 10.3390/ijerph18073554. Int J Environ Res Public Health. 2021. PMID: 33808066 Free PMC article.
Lower SARS-CoV-2-specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19.
Schuster DJ, Karuna S, Brackett C, Wesley M, Li SS, Eisel N, Tenney D, Hilliard S, Yates NL, Heptinstall JR, Williams LD, Shen X, Rolfe R, Cabello R, Zhang L, Sawant S, Hu J, Randhawa AK, Hyrien O, Hural JA, Corey L, Frank I, Tomaras GD, Seaton KE; HVTN 405/HPTN 1901 Study Team. Schuster DJ, et al. JCI Insight. 2022 Nov 8;7(21):e158402. doi: 10.1172/jci.insight.158402. JCI Insight. 2022. PMID: 36136590 Free PMC article.
Anti-SARS-CoV-2 Antibody Level Is Associated with a History of COVID-19 Infection and mRNA Vaccination in Patients with Diabetes.
Hataul IAH, Soetedjo NNM, Debora J, Tiara MR, Djauhari H, Susandi E, Alisjahbana B, Wisaksana R, Permana H. Hataul IAH, et al. Vaccines (Basel). 2023 Aug 27;11(9):1424. doi: 10.3390/vaccines11091424. Vaccines (Basel). 2023. PMID: 37766101 Free PMC article.

See all "Cited by" articles

References

1. Liu Z.L., Liu Y., Wan L.G., Xiang T.X., Le A.P., Liu P. Antibody profiles in mild and severe cases of COVID-19. Clin Chem (Baltimore, Md.) 2020;66(8):1102–1104. doi: 10.1093/clinchem/hvaa137. https://search.proquest.com/docview/2412221239 - DOI - PMC - PubMed
1. Overton E.T., Sungkanuparph S., Powderly W.G., Seyfried W., Groger R.K., Aberg J.A. Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons. Clin Infect Dis. 2005;41(7):1045–1048. - PubMed
1. Wang M., Luo L., Bu H., Xia H. One case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a low CD4(+) T-cell count. Int J Infect Dis. 2020;96:148–150. - PMC - PubMed
1. Jelicic K., Cimbro R., Nawaz F., Huang D.W., Zheng X., Yang J. The HIV-1 envelope protein gp120 impairs B cell proliferation by inducing TGF-β1 production and FcRL4 expression. Nat Immunol. 2013;14(12):1256–1265. - PMC - PubMed
1. Choe P.G., Kang C.K., Suh H.J., Jung J., Kang E.K., Lee S.Y. Antibody Responses to SARS-CoV-2 at 8 weeks postinfection in asymptomatic patients. Emerg Infect Dis. 2020 Sep doi: 10.3201/eid2610.202211. [Online ahead of print] - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

[1] Liu Z.L., Liu Y., Wan L.G., Xiang T.X., Le A.P., Liu P. Antibody profiles in mild and severe cases of COVID-19. Clin Chem (Baltimore, Md.) 2020;66(8):1102–1104. doi: 10.1093/clinchem/hvaa137. https://search.proquest.com/docview/2412221239 - DOI - PMC - PubMed

[2] Liu Z.L., Liu Y., Wan L.G., Xiang T.X., Le A.P., Liu P. Antibody profiles in mild and severe cases of COVID-19. Clin Chem (Baltimore, Md.) 2020;66(8):1102–1104. doi: 10.1093/clinchem/hvaa137. https://search.proquest.com/docview/2412221239 - DOI - PMC - PubMed

[3] Overton E.T., Sungkanuparph S., Powderly W.G., Seyfried W., Groger R.K., Aberg J.A. Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons. Clin Infect Dis. 2005;41(7):1045–1048. - PubMed

[4] Overton E.T., Sungkanuparph S., Powderly W.G., Seyfried W., Groger R.K., Aberg J.A. Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons. Clin Infect Dis. 2005;41(7):1045–1048. - PubMed

[5] Wang M., Luo L., Bu H., Xia H. One case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a low CD4(+) T-cell count. Int J Infect Dis. 2020;96:148–150. - PMC - PubMed

[6] Wang M., Luo L., Bu H., Xia H. One case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a low CD4(+) T-cell count. Int J Infect Dis. 2020;96:148–150. - PMC - PubMed

[7] Jelicic K., Cimbro R., Nawaz F., Huang D.W., Zheng X., Yang J. The HIV-1 envelope protein gp120 impairs B cell proliferation by inducing TGF-β1 production and FcRL4 expression. Nat Immunol. 2013;14(12):1256–1265. - PMC - PubMed

[8] Jelicic K., Cimbro R., Nawaz F., Huang D.W., Zheng X., Yang J. The HIV-1 envelope protein gp120 impairs B cell proliferation by inducing TGF-β1 production and FcRL4 expression. Nat Immunol. 2013;14(12):1256–1265. - PMC - PubMed

[9] Choe P.G., Kang C.K., Suh H.J., Jung J., Kang E.K., Lee S.Y. Antibody Responses to SARS-CoV-2 at 8 weeks postinfection in asymptomatic patients. Emerg Infect Dis. 2020 Sep doi: 10.3201/eid2610.202211. [Online ahead of print] - DOI - PMC - PubMed

[10] Choe P.G., Kang C.K., Suh H.J., Jung J., Kang E.K., Lee S.Y. Antibody Responses to SARS-CoV-2 at 8 weeks postinfection in asymptomatic patients. Emerg Infect Dis. 2020 Sep doi: 10.3201/eid2610.202211. [Online ahead of print] - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Antibody response to SARS-CoV-2 in people living with HIV

Affiliations

Antibody response to SARS-CoV-2 in people living with HIV

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous